Avenue therapeutics announces publication of tramadol non-medical use in four european countries: a comparative analysis

New york, dec. 18, 2020 (globe newswire) -- avenue therapeutics, inc. (nasdaq: atxi) (avenue), a company focused on the development of intravenous (iv) tramadol for the u.s. market, today announced that a publication titled “tramadol non-medical use in four european countries: a comparative analysis” has been published in drug and alcohol dependence, a peer-reviewed international journal devoted to research, reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. the publication can be accessed here.
ATXI Ratings Summary
ATXI Quant Ranking